Literature DB >> 16681637

Somatic hypermutation and VH gene usage in hairy cell leukaemia.

Evgeny Arons1, Joel Sunshine, Tara Suntum, Robert J Kreitman.   

Abstract

To examine the usage and mutational status of VH genes in hairy cell leukaemia (HCL), we analysed 24 immunoglobulin heavy chain (IgH) sequences expressed in 23 patients. None had premature stop codons. VH3-23 was the most common gene and a VH6 gene was observed for the first time in HCL. Although the mean mutation frequency was 6.1%, slightly higher than in previous HCL series, four patients had 99.6-100% homology to germline sequences, three of whom had high tumour burdens and poor outcomes. Despite the high mutation frequency, only two of 24 rearrangements had clear statistical evidence of antigen-dependent somatic mutation. Our results increase the database of reported functional HCL rearrangements to 94 in 92 patients. Overall, both gene usage and mutation frequency are very similar to mucosa-associated lymphoid tissue-type marginal zone lymphoma. The data are consistent with HCL originating from post-germinal centre marginal zone B cells, although the heterogeneity observed suggests that HCL may originate differently in some patients, and this could have implications for prognosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681637     DOI: 10.1111/j.1365-2141.2006.06066.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  PRAME expression in hairy cell leukemia.

Authors:  Evgeny Arons; Tara Suntum; Inger Margulies; Constance Yuan; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Leuk Res       Date:  2008-03-04       Impact factor: 3.156

2.  Evidence of canonical somatic hypermutation in hairy cell leukemia.

Authors:  Evgeny Arons; Laura Roth; Jeffrey Sapolsky; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2011-03-02       Impact factor: 22.113

3.  Molecular variant of hairy cell leukemia with poor prognosis.

Authors:  Evgeny Arons; Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2011-06

4.  Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.

Authors:  Evgeny Arons; Sharon Adams; David J Venzon; Ira Pastan; Robert J Kreitman
Journal:  Br J Haematol       Date:  2014-06-13       Impact factor: 6.998

Review 5.  How I treat hairy cell leukemia.

Authors:  Michael R Grever
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

6.  VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

Authors:  Evgeny Arons; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2009-09-10       Impact factor: 22.113

Review 7.  CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.

Authors:  John J Schmieg; Jeannie M Muir; Nadine S Aguilera; Aaron Auerbach
Journal:  Curr Oncol       Date:  2021-12-04       Impact factor: 3.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.